Rationale and Design of the PASSIVATE‐CAP Trial: The Preventive Intervention Value of Drug‐Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques
The PASSIVATE-CAP study represents the first prospective, randomized, multicenter, open-label trial designed to explore the therapeutic value of DCB for the treatment of vulnerable plaques within the ACS patient population.
Authors
- Zhongxiu Chen
- Jiafu Wei (ORCID: https://orcid.org/0000-0003-3827-7622)
- M. Wang (ORCID: https://orcid.org/0000-0002-4713-9646)
- Chen Li (ORCID: https://orcid.org/0000-0003-2748-8707)
- Baotao Huang
- Junyan Zhang
- Hua Wang
- Shichu Liang
- Yong Chen
- for the PASSIVATE‐CAP trial investigator
- Yong He
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Clinical Cardiology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/clc.70243
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00